Hypersonics and Critical Munitions Company Ursa Major to Go Public
25-08-2026 12:00 via prnewswire.com

Hypersonics and Critical Munitions Company Ursa Major to Go Public

The business combination with Inflection Point-led SPAC expected to provide at least $350 million in committed capital to rapidly scale defense industrial base production DENVER, Aug. 25, 2026 /PRNewswire/ -- Ursa Major Technologies, Inc., an aerospace and defense company building...
Read more »

PR Public relations news



/C O R R E C T I O N -- OPAQUE/
/C O R R E C T I O N -- OPAQUE/
AMPERA UND DAS LAWRENCE LIVERMORE NATIONAL LABORATORY GEBEN STRATEGISCHE PARTNERSCHAFT ZUR ENTWICKLUNG FORTSCHRITTLICHER KERNBRENNSTOFFE BEKANNT
AMPERA UND DAS LAWRENCE LIVERMORE NATIONAL LABORATORY GEBEN STRATEGISCHE PARTNERSCHAFT ZUR ENTWICKLUNG FORTSCHRITTLICHER KERNBRENNSTOFFE BEKANNT
Robbins LLP Reminds PLNT Investors of the Pending Lead Plaintiff Deadline in the Securities Class Action Lawsuit Against Planet Fitness, Inc.
Robbins LLP Reminds PLNT Investors of the Pending Lead Plaintiff Deadline in the Securities Class Action Lawsuit Against Planet Fitness, Inc.
Custom Home Builder Expert Cole Glascock Explains How to Design a Lake of the Ozarks Home in HelloNation
Custom Home Builder Expert Cole Glascock Explains How to Design a Lake of the Ozarks Home in HelloNation
TBLA Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Taboola.com Ltd.
TBLA Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Taboola.com Ltd.
New Dx World Summit to Unite the Global Diagnostics Ecosystem in Washington, D.C., August 23-25, 2027
New Dx World Summit to Unite the Global Diagnostics Ecosystem in Washington, D.C., August 23-25, 2027
Greenberg Traurig Deploys the Next Generation of CoCounsel Legal
Greenberg Traurig Deploys the Next Generation of CoCounsel Legal
Capital Group Announces Appointment of New Chief Information Officer
Capital Group Announces Appointment of New Chief Information Officer
AMPERA ET LE LABORATOIRE NATIONAL LAWRENCE LIVERMORE ANNONCENT UN PARTENARIAT STRATÉGIQUE POUR LE DÉVELOPPEMENT DE COMBUSTIBLES NUCLÉAIRES DE NOUVELLE GÉNÉRATION
AMPERA ET LE LABORATOIRE NATIONAL LAWRENCE LIVERMORE ANNONCENT UN PARTENARIAT STRATÉGIQUE POUR LE DÉVELOPPEMENT DE COMBUSTIBLES NUCLÉAIRES DE NOUVELLE GÉNÉRATION
Action1 Expands Endpoint Management with New Configuration Management and Enrollment and Provisioning Modules
Action1 Expands Endpoint Management with New Configuration Management and Enrollment and Provisioning Modules
Robbins LLP Urges PNR Stockholders Who Lost Money Investing in Pentair plc. To Contact the Firm for Information About Leading the Class Action
Robbins LLP Urges PNR Stockholders Who Lost Money Investing in Pentair plc. To Contact the Firm for Information About Leading the Class Action
Horticulture Co., a Leading U.S. Beverage Company focused on Hemp-Derived THC and Functional Adult Beverages, Sees Tremendous Success From 112.5% YoY Growth to Expansion into New Markets, Securement of New Retailers Including ABC Fine Wine & Spiri
Horticulture Co., a Leading U.S. Beverage Company focused on Hemp-Derived THC and Functional Adult Beverages, Sees Tremendous Success From 112.5% YoY Growth to Expansion into New Markets, Securement of New Retailers Including ABC Fine Wine & Spiri
Horticulture Co., a Leading U.S. Beverage Company focused on Hemp-Derived THC and Functional Adult Beverages, Sees Tremendous Success From 112.5% YoY Growth to Expansion into New Markets, Securement of New Retailers Including ABC Fine Wine & Spiri
Horticulture Co., a Leading U.S. Beverage Company focused on Hemp-Derived THC and Functional Adult Beverages, Sees Tremendous Success From 112.5% YoY Growth to Expansion into New Markets, Securement of New Retailers Including ABC Fine Wine & Spiri
Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA
Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA
Desktop versie